Full text is available at the source.
Abstract
A detection limit as low as 37 fM was achieved for microRNAs using a novel biosensing platform.
- The biosensing platform integrates catalytic hairpin assembly and hybridization chain reaction with the CRISPR/Cas12a system.
- It demonstrates high sensitivity for target microRNAs, enabling effective detection even in complex biological samples.
- The platform exhibits remarkable capability to distinguish sequences with single-nucleotide mismatches.
- Stable and reliable performance was observed in serum samples and lysates from various tumor cells.
- The approach combines signal amplification with the CRISPR system, potentially enhancing specificity in miRNA detection.
Simplified